Showing 1 - 10 of 58
Persistent link: https://www.econbiz.de/10003503497
Persistent link: https://www.econbiz.de/10012808337
Epidemiological studies report confidence or uncertainty intervals around their estimates. Estimates of the burden of diseases and risk factors are subject to a broader range of uncertainty because of the combination of multiple data sources and value choices. Sensitivity analysis can be used to...
Persistent link: https://www.econbiz.de/10009447940
Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced...
Persistent link: https://www.econbiz.de/10014502358
Background: Little is known about the long-term drug costs associated with treating AIDS in developing countries. Brazil's AIDS treatment program has been cited widely as the developing world's largest and most successful AIDS treatment program. The program guarantees free access to highly...
Persistent link: https://www.econbiz.de/10009431983
Background: In survey studies on health-state valuations, ordinal ranking exercises often are used as precursors to other elicitation methods such as the time trade-off (TTO) or standard gamble, but the ranking data have not been used in deriving cardinal valuations. This study reconsiders the...
Persistent link: https://www.econbiz.de/10009431988
Philip Clarke and colleagues examined patient-level data for over 11,000 participants with type 2 diabetes from 20 countries and find that major complications of diabetes significantly increased hospital use and costs across settings. Background: Diabetes imposes a substantial burden globally in...
Persistent link: https://www.econbiz.de/10009431991
Persistent link: https://www.econbiz.de/10009489299
Persistent link: https://www.econbiz.de/10001766530
Persistent link: https://www.econbiz.de/10011609398